TY - JOUR
T1 - Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells
AU - Bergmini, Alberto
AU - Dini, Luciana
AU - Baiocchi, Leonardo
AU - Cappannoli, Luisa
AU - Falasca, Laura
AU - Bolacchi, Francesca
AU - Capozzi, Marcella
AU - Faggioli, Emanuela
AU - Nistri, Alessandra
AU - Salanitro, Agata
AU - Ventura, Laura
AU - Rocchi, Giovanni
AU - Angelico, Mario
PY - 1997
Y1 - 1997
N2 - Bile acids have been proposed to exert immunological effects of potential pathogenic or therapeutic relevance, yet the experimental evidence remains preliminary. We reexamined the effects of a variety of bile salts with differing hydrophilic-hydrophobic properties on the production of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) from monocytes and Kupffer cells. Monocytes from healthy human donors and Kupffer cells from 5- week-old mice were incubated for up to 18 hours with or without varying concentrations of bile salts and lipopolysaccharide (LPS). Monocyte viability was ≤95% with up to 250 μmol/L sodium ursodeoxycholate and ≤90% with 200 μmol/L chenodeoxycholate, decreasing sharply at higher concentrations. Kupffer cells were moro vulnerable, particularly to chenodeoxycholate (viabilities of 25% and 0% at concentrations of 100 μmol/L and 200 μmol/L, respectively). In monocytes incubated in the presence of 20% fetal calf serum, neither ursodeoxycholate and chenodeoxycholate, nor a variety of other unconjugated and conjugated bile acids, tested up to their maximal noncytotoxic concentrations, influenced the IL-6 and TNFα production, at any level of LPS stimulation. Similar to monocytes, incubation of murine Kupffer cells with ursodeoxycholate and chenodeoxycholate did not influence cytokine release. In contrast, the addition of 10 nmol/L dexamethasone to monocytes significantly decreased TNF-α and IL-6 release (69 ± 11% and 48 ± 15%, respectively). When monocytes were incubated with 200 μmol/L chenodeoxycholate in the presence of lower concentrations of fetal calf serum (10% and 5%, respectively) a significant inhibition of cytokine release was observed, whereas incubation with ursodeoxycholate did not cause any effect. Flow cytometry using fluoresceinated LPS showed that chenodeoxycholate does not interact with the CD14 receptor, thus excluding the possibility of an interference with the LPS uptake by monocytes. Incubation with [14C]- chenodeoxycholate showed that the intracellular bile acid uptake was inversely related to the concentration of fetal calf serum, being negligible (
AB - Bile acids have been proposed to exert immunological effects of potential pathogenic or therapeutic relevance, yet the experimental evidence remains preliminary. We reexamined the effects of a variety of bile salts with differing hydrophilic-hydrophobic properties on the production of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) from monocytes and Kupffer cells. Monocytes from healthy human donors and Kupffer cells from 5- week-old mice were incubated for up to 18 hours with or without varying concentrations of bile salts and lipopolysaccharide (LPS). Monocyte viability was ≤95% with up to 250 μmol/L sodium ursodeoxycholate and ≤90% with 200 μmol/L chenodeoxycholate, decreasing sharply at higher concentrations. Kupffer cells were moro vulnerable, particularly to chenodeoxycholate (viabilities of 25% and 0% at concentrations of 100 μmol/L and 200 μmol/L, respectively). In monocytes incubated in the presence of 20% fetal calf serum, neither ursodeoxycholate and chenodeoxycholate, nor a variety of other unconjugated and conjugated bile acids, tested up to their maximal noncytotoxic concentrations, influenced the IL-6 and TNFα production, at any level of LPS stimulation. Similar to monocytes, incubation of murine Kupffer cells with ursodeoxycholate and chenodeoxycholate did not influence cytokine release. In contrast, the addition of 10 nmol/L dexamethasone to monocytes significantly decreased TNF-α and IL-6 release (69 ± 11% and 48 ± 15%, respectively). When monocytes were incubated with 200 μmol/L chenodeoxycholate in the presence of lower concentrations of fetal calf serum (10% and 5%, respectively) a significant inhibition of cytokine release was observed, whereas incubation with ursodeoxycholate did not cause any effect. Flow cytometry using fluoresceinated LPS showed that chenodeoxycholate does not interact with the CD14 receptor, thus excluding the possibility of an interference with the LPS uptake by monocytes. Incubation with [14C]- chenodeoxycholate showed that the intracellular bile acid uptake was inversely related to the concentration of fetal calf serum, being negligible (
UR - http://www.scopus.com/inward/record.url?scp=0030947259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030947259&partnerID=8YFLogxK
U2 - 10.1002/hep.510250423
DO - 10.1002/hep.510250423
M3 - Article
C2 - 9096599
AN - SCOPUS:0030947259
VL - 25
SP - 927
EP - 933
JO - Hepatology
JF - Hepatology
SN - 0270-9139
IS - 4
ER -